LENZ · XBRL financial data

LENZ Therapeutics financial statements, every fiscal year

The same tables from 5 filings, lined up. Matched by XBRL tag: renamed lines keep their history.

How these numbers work

Every number comes from the company's XBRL financial data filed with the SEC, and each one links to its filing.
Lines are matched by XBRL tag, so a line renamed between filings keeps its history.
* marks a quarter worked out from the filing totals: the 10-K year minus the first three quarters, or a year-to-date total minus the earlier one. Fourth-quarter earnings per share is fourth-quarter net income over the fourth-quarter weighted shares.
0 means a filing states zero; a dash (—) means no filing states that number.
“year only” means the 10-K gives the full year but not the quarters needed to work out the fourth. A worked-out quarter of revenue, cost of revenue or operating cash flow more than twice the company's largest quarter of the two years before is shown this way too.
Gross profit is shown as the company reports it; a worked-out quarter must equal revenue less cost of revenue for that quarter, or it is a dash.
Operating income can be above gross profit when the company books other operating income between the two, shown on its own line.
Shares outstanding come from each filing's cover page, as of the date printed there.
Quarters are fiscal: Q2 FY27 is the second quarter of the company's fiscal 2027.

Income statement

Fiscal years (LENZ's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Revenue from contracts with customers	—	—	—	0	19,088
Cost of goods and services sold	—	—	—	0	418
Research and development	37,932	72,787	32,137	29,801	18,670
Selling, general and administrative	—	—	12,925	28,809	91,138
General and administrative	22,511	32,852	40,973	—	—
Total operating expenses	60,443	105,639	135,191	58,610	—
Operating income (loss)	(60,443)	(105,639)	(135,191)	(58,610)	(91,138)
Interest income	—	—	2,189	8,553	9,756
Other income (expense)	24	4,587	10,949	289	(243)
Income tax expense (benefit)	0	0	(179)	1	502
Net income (loss)	(70,760)	(101,052)	(124,651)	(49,769)	(82,127)
Earnings per share, basic USD per share	(2.45)	(1.84)	(2.19)	(2.34)	(2.85)
Earnings per share, diluted USD per share	(2.45)	(1.84)	(2.19)	(2.34)	(2.85)
Weighted average shares, basic thousands of shares	28,919	54,874	57,015	21,281	28,813
Weighted average shares, diluted thousands of shares	28,919	54,874	57,015	21,281	28,813

Fiscal years (LENZ's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Cash and cash equivalents	376,976	47,730	184,259	20,158	25,179
Marketable securities	0	220,499	0	—	—
Marketable securities, non-current	0	15,322	0	—	—
Accounts receivable	—	—	—	0	329
Inventory	—	—	—	0	2,936
Prepaid and other current assets	4,760	7,136	2,160	2,773	5,800
Total current assets	381,736	275,365	188,021	211,917	301,412
Property and equipment, net	6,507	22,630	0	651	1,189
Right-of-use asset	11,574	5,580	321	1,338	734
Total assets	401,987	321,902	188,456	215,304	305,876
Accounts payable	2,453	2,608	250	4,257	4,167
Accrued liabilities	—	—	12,803	6,149	17,020
Total current liabilities	12,143	13,043	4,797	10,406	21,187
Lease liability, non-current	5,794	1,749	77	814	350
Total liabilities	17,937	25,611	4,874	11,220	21,537
Accumulated deficit	(141,351)	(242,403)	(367,054)	(145,014)	(227,141)
Total stockholders' equity	384,050	296,291	183,582	204,084	284,339
Total liabilities and equity	401,987	321,902	188,456	215,304	305,876
Common shares outstanding (cover page) thousands of shares	58,011	58,164	58,237	27,543	31,354

Fiscal years (LENZ's year ends in late December)

In thousands of dollars	FY 2021Dec 31, 2021	FY 2022Dec 31, 2022	FY 2023Dec 31, 2023	FY 2024Dec 31, 2024	FY 2025Dec 31, 2025
Net income (loss)	(70,760)	(101,052)	(124,651)	(49,769)	(82,127)
Stock-based compensation	7,871	13,534	10,574	6,365	12,547
Depreciation and amortization	—	—	15	58	287
Net cash from operating activities	(52,852)	(87,980)	(90,007)	(59,391)	(69,170)
Purchases of property and equipment	5,740	6,594	10,856	468	827
Net cash from investing activities	(5,740)	(241,863)	226,346	(154,479)	(75,668)
Proceeds from issuing common stock	—	—	0	79,513	—
Net cash from financing activities	417,467	597	190	199,002	149,745
Net change in cash	358,875	(329,246)	136,529	(14,868)	4,907

The peer list for this company is being put together from its industry's latest filings. Reload the page in a minute to see it.

Not investment advice. Not affiliated with the U.S. SEC.